Header Logo

Connection

Gary Reubenson to Humans

Back to Details
This is a "connection" page, showing publications Gary Reubenson has written about Humans.
Gary Reubenson
Connection Strength
0,494
Humans
  1. Meta-analytic magic, ivermectin, and socially responsible reporting. S Afr Med J. 2021 08 17; 111(10):934-937.
    View in: PubMed
    Score: 0,059
  2. Pediatric drug-resistant tuberculosis: a global perspective: a global perspective. Paediatr Drugs. 2011 Dec 01; 13(6):349-55.
    View in: PubMed
    Score: 0,030
  3. Risk Factors for Severe COVID-19 Among Children and Adolescents Enrolled in Acute Respiratory Infection Sentinel Surveillance in South Africa, 2020-2022. Influenza Other Respir Viruses. 2024 May; 18(5):e13300.
    View in: PubMed
    Score: 0,018
  4. Genomic characterization of Bordetella pertussis in South Africa, 2015-2019. Microb Genom. 2023 Dec; 9(12).
    View in: PubMed
    Score: 0,017
  5. International Pediatric COVID-19 Severity Over the Course of the Pandemic. JAMA Pediatr. 2023 10 01; 177(10):1073-1084.
    View in: PubMed
    Score: 0,017
  6. Changing Epidemiology of COVID-19 in Children and Adolescents Over Four Successive Epidemic Waves in South Africa, 2020-2022. J Pediatric Infect Dis Soc. 2023 Apr 18; 12(3):128-134.
    View in: PubMed
    Score: 0,017
  7. Bronchiolitis versus bronchopneumonia: navigating antibiotic use within the LRTI spectrum. S Afr Med J. 2023 03 20; 113(6):20-23.
    View in: PubMed
    Score: 0,017
  8. Impact of the COVID-19 pandemic on TB services at ART programmes in low- and middle-income countries: a multi-cohort survey. J Int AIDS Soc. 2022 10; 25(10):e26018.
    View in: PubMed
    Score: 0,016
  9. Case-fatality and sequelae following acute bacterial meningitis in South Africa, 2016 through 2020. Int J Infect Dis. 2022 Sep; 122:1056-1066.
    View in: PubMed
    Score: 0,016
  10. Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Euro Surveill. 2021 07; 26(29).
    View in: PubMed
    Score: 0,015
  11. Trends in RPR Seropositivity among Children Younger than 2 Years in South Africa, 2010-2019. J Trop Pediatr. 2021 01 29; 67(1).
    View in: PubMed
    Score: 0,014
  12. Parental access to hospitalised children during infectious disease pandemics such as COVID-19. S Afr Med J. 2021 01 20; 111(2):100-105.
    View in: PubMed
    Score: 0,014
  13. Trends in paediatric tuberculosis diagnoses in two South African hospitals early in the COVID-19 pandemic. S Afr Med J. 2020 11 02; 110(12):1149-1150.
    View in: PubMed
    Score: 0,014
  14. Essential medicine selection during the COVID-19 pandemic: Enabling access in uncharted territory. S Afr Med J. 2020 09 29; 110(11):1077-1080.
    View in: PubMed
    Score: 0,014
  15. National Neonatal Sepsis Task Force launch: Supporting infection prevention and surveillance, outbreak investigation and antimicrobial stewardship in neonatal units in South Africa. S Afr Med J. 2020 Apr 29; 110(5):360-363.
    View in: PubMed
    Score: 0,014
  16. Towards understanding global patterns of antimicrobial use and resistance in neonatal sepsis: insights from the NeoAMR network. Arch Dis Child. 2020 01; 105(1):26-31.
    View in: PubMed
    Score: 0,013
  17. Declining Incidence of Invasive Meningococcal Disease in South Africa: 2003-2016. Clin Infect Dis. 2019 07 18; 69(3):495-504.
    View in: PubMed
    Score: 0,013
  18. Congenital Rubella Syndrome Surveillance in South Africa Using a Sentinel Site Approach: A Cross-sectional Study. Clin Infect Dis. 2019 05 02; 68(10):1658-1664.
    View in: PubMed
    Score: 0,013
  19. Invasive Pneumococcal Disease in Neonates Prior to Pneumococcal Conjugate Vaccine Use in South Africa: 2003-2008. Pediatr Infect Dis J. 2019 04; 38(4):424-430.
    View in: PubMed
    Score: 0,013
  20. Molecular Detection of Mycobacterium tuberculosis from Stools in Young Children by Use of a Novel Centrifugation-Free Processing Method. J Clin Microbiol. 2018 09; 56(9).
    View in: PubMed
    Score: 0,012
  21. Site Variability in Regulatory Oversight for an International Study of Pediatric Sepsis. Pediatr Crit Care Med. 2018 Apr; 19(4):e180-e188.
    View in: PubMed
    Score: 0,012
  22. Risk factors for pertussis among hospitalized children in a high HIV prevalence setting, South Africa. Int J Infect Dis. 2018 Mar; 68:54-60.
    View in: PubMed
    Score: 0,012
  23. Tuberculosis Treatment Outcomes Among HIV/TB-Coinfected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network. J Acquir Immune Defic Syndr. 2017 Jun 01; 75(2):156-163.
    View in: PubMed
    Score: 0,011
  24. Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study. Lancet Glob Health. 2017 03; 5(3):e359-e369.
    View in: PubMed
    Score: 0,011
  25. Correlates of protection of serotype-specific capsular antibody and invasive Group B Streptococcus disease in South African infants. Vaccine. 2015 Nov 27; 33(48):6793-9.
    View in: PubMed
    Score: 0,010
  26. Association between maternal Group B Streptococcus surface-protein antibody concentrations and invasive disease in their infants. Expert Rev Vaccines. 2015; 14(12):1651-60.
    View in: PubMed
    Score: 0,010
  27. Updated recommendations for the management of upper respiratory tract infections in South Africa. S Afr Med J. 2015 Apr 06; 105(5):344-52.
    View in: PubMed
    Score: 0,010
  28. Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013. Clin Infect Dis. 2015 May 01; 60(9):1346-56.
    View in: PubMed
    Score: 0,009
  29. Risk factors for invasive pneumococcal disease among children less than 5 years of age in a high HIV prevalence setting, South Africa, 2010 to 2012. Pediatr Infect Dis J. 2015 Jan; 34(1):27-34.
    View in: PubMed
    Score: 0,009
  30. Effectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in HIV-infected and -uninfected children in south africa: a matched case-control study. Clin Infect Dis. 2014 Sep 15; 59(6):808-18.
    View in: PubMed
    Score: 0,009
  31. Tuberculosis in Pediatric Antiretroviral Therapy Programs in Low- and Middle-Income Countries: Diagnosis and Screening Practices. J Pediatric Infect Dis Soc. 2015 Mar; 4(1):30-8.
    View in: PubMed
    Score: 0,009
  32. Poor early virologic performance and durability of abacavir-based first-line regimens for HIV-infected children. Pediatr Infect Dis J. 2013 Aug; 32(8):851-5.
    View in: PubMed
    Score: 0,008
  33. High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study. BMC Infect Dis. 2011 Jan 26; 11:28.
    View in: PubMed
    Score: 0,007
  34. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study. Lancet. 2010 May 22; 375(9728):1798-807.
    View in: PubMed
    Score: 0,007
  35. Meconium peritonitis and parvovirus B19 infection associated with hydrops fetalis. Ann Trop Paediatr. 2006 Dec; 26(4):371-5.
    View in: PubMed
    Score: 0,005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.